Correlation Between Viracta Therapeutics and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Viracta Therapeutics and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Actinium Pharmaceuticals.
Diversification Opportunities for Viracta Therapeutics and Actinium Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Viracta and Actinium is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Actinium Pharmaceuticals
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Actinium Pharmaceuticals. In addition to that, Viracta Therapeutics is 2.63 times more volatile than Actinium Pharmaceuticals. It trades about -0.17 of its total potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.04 per unit of volatility. If you would invest 141.00 in Actinium Pharmaceuticals on December 2, 2024 and sell it today you would lose (26.00) from holding Actinium Pharmaceuticals or give up 18.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 73.77% |
Values | Daily Returns |
Viracta Therapeutics vs. Actinium Pharmaceuticals
Performance |
Timeline |
Viracta Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Actinium Pharmaceuticals |
Viracta Therapeutics and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viracta Therapeutics and Actinium Pharmaceuticals
The main advantage of trading using opposite Viracta Therapeutics and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Actinium Pharmaceuticals vs. Mink Therapeutics | Actinium Pharmaceuticals vs. Affimed NV | Actinium Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Actinium Pharmaceuticals vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Transaction History View history of all your transactions and understand their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |